V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004005 | 10002526 | 1.6 | 76.8 | Palliative (P) | 2018-11-30 | 2018-12-11 | Irinotecan + Modified De Gramont | 2 | N | 10504526 | IRINOTECAN + MDG |
| 10004006 | 10002526 | 0 | 75.9 | Neo-adjuvant (N) | 2015-01-20 | 2015-01-20 | CAPECITABINE + RT | 2 | Y | 10504526 | CAPECITABINE + RT |
| 10004007 | 10002527 | 1.57 | 64.5 | Adjuvant (A) | 2018-07-13 | 2018-07-21 | FEC + DOCETAXEL | 2 | N | 10504685 | FEC + DOCETAXEL |
| 10004008 | 10002527 | 1.72 | 54.4 | Disease modification (D) | 2014-08-09 | 2014-08-10 | Bortezomib +/- Dexamethasone | 02 | N | 10504685 | CTD |
| 10004009 | 10002527 | 1.8 | 80.5 | null | 2017-09-29 | 2017-10-15 | BCG Intravesical | N | N | 10504685 | CTD |
| 10004010 | 10002528 | 1.66 | 71.7 | a | 2015-04-15 | 2015-05-05 | Fluorouracil+Mitomycin+RT (Bladder) | N | N | 10504897 | BCG |
| 10004011 | 10006560 | 0 | 66.2 | Adjuvant (A) | 2019-02-05 | 2019-02-26 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10504969 | FLUOROURACIL |
| 10004012 | 10006560 | 0 | 55.9 | Curative (C) | 2014-09-20 | 2014-09-21 | Bortezomib (weekly) | 02 | N | 10504969 | CVD |
| 10004013 | 10002529 | 1.6 | 72.6 | Adjuvant (A) | 2018-03-25 | 2018-03-27 | CVD | 2 | N | 10505004 | IMATINIB |
| 10004014 | 10002530 | 1.6 | 61.5 | Palliative (P) | 2018-03-18 | 2018-04-16 | ABVD | N | N | 10505076 | TEMOZOLOMIDE + RT |
| 10004015 | 10002530 | 1.76 | 85 | Curative (C) | 2017-08-14 | 2017-08-14 | FEC + DOCETAXEL | 02 | N | 10505076 | FEC + DOCETAXEL |
| 10004016 | 10002531 | null | null | Palliative (P) | 2016-02-28 | 2016-03-15 | ABVD | N | null | 10505104 | CVD |
| 10004017 | 10002532 | 0 | 0 | Palliative (P) | 2016-01-20 | 2016-02-04 | Fluorouracil + Folinic Acid Weekly | N | N | 10505187 | FLUOROURACIL |
| 10004018 | 10006562 | 1.8 | 74.7 | Curative (C) | 2017-02-13 | 2017-02-26 | Capecitabine + Cisplatin | N | N | 10505246 | CHLORAMBUCIL |
| 10004019 | 10002533 | 1.7 | 81.6 | Palliative (P) | 2018-04-05 | 2018-04-12 | Capecitabine + Cisplatin | null | N | 10505302 | ABIRATERONE |
| 10004020 | 10002534 | null | 68.5 | Curative (C) | 2015-06-12 | 2015-07-05 | Cisplatin + Radiotherapy | N | null | 10505307 | CISPLATIN + RT |
| 10004021 | 10002535 | 1.69 | 63.7 | Palliative (P) | 2016-06-10 | 2016-06-23 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10505405 | CAPECITABINE + CISPLATIN |
| 10004022 | 10002535 | 1.82 | 61 | Palliative (P) | 2016-12-11 | 2016-12-27 | Paclitaxel 7 day | N | N | 10505405 | IMATINIB |
| 10004023 | 10002536 | 1.78 | 0 | Adjuvant (A) | 2018-05-25 | 2018-06-07 | FEC + DOCETAXEL | 2 | N | 10505550 | FEC + DOCETAXEL |
| 10004024 | 10002537 | 1.67 | 65 | null | 2017-06-14 | 2017-06-29 | Cisplatin + Radiotherapy | 02 | null | 10505559 | CISPLATIN + RT |
| 10004025 | 10006564 | 1.64 | 51.6 | Curative (C) | 2017-07-04 | 2017-07-27 | Cisplatin + Radiotherapy | N | Y | 10505569 | CISPLATIN + RT |
| 10004026 | 10006564 | 1.72 | 0 | Palliative (P) | 2016-04-16 | 2016-04-16 | Chlorambucil | N | N | 10505569 | CISPLATIN |
| 10004027 | 10002538 | 1.62 | 58.1 | Disease modification (D) | 2015-04-04 | 2015-04-05 | CVD | 02 | N | 10505645 | CHLORAMBUCIL |
| 10004028 | 10002539 | null | 81.3 | Curative (C) | 2015-08-28 | 2015-09-08 | CTD | 02 | N | 10505656 | FLUOROURACIL + MITOMYCIN + RT |
| 10004029 | 10002540 | 1.77 | 118 | Curative (C) | 2015-02-03 | 2015-02-12 | Cisplatin + Radiotherapy | N | null | 10505773 | CISPLATIN + RT |
| 10004030 | 10002540 | 1.61 | 100.5 | Neo-adjuvant (N) | 2015-05-29 | 2015-06-05 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10505773 | CISPLATIN + ETOPOSIDE |
| 10004031 | 10002541 | 1.8 | null | Curative (C) | 2019-01-09 | 2019-01-10 | CAPECITABINE + RT | 02 | Y | 10505846 | CAPECITABINE + RT |
| 10004032 | 10002542 | 1.77 | null | null | 2018-11-14 | 2018-12-03 | Gemcitabine + Capecitabine | N | N | 10505847 | CAPECITABINE + GEMCITABINE |
| 10004033 | 10006566 | 1.74 | 108 | Not known (9) | 2015-09-22 | 2015-09-23 | EC | N | N | 10505875 | IMATINIB |
| 10004034 | 10002543 | 1.75 | 89 | null | 2019-05-19 | 2019-06-06 | Cisplatin 7 day | 2 | Y | 10505882 | BCG |
| 10004035 | 10002544 | 0 | 69 | Adjuvant (A) | 2018-01-14 | 2018-01-28 | Azacitidine | N | N | 10505891 | IMATINIB |
| 10004036 | 10002545 | null | 81 | Neo-adjuvant (N) | 2017-02-04 | 2017-02-04 | FEC 100 + DOCETAXEL | 02 | N | 10505925 | FEC + DOCETAXEL |
| 10004037 | 10002546 | null | null | Curative (C) | 2018-02-04 | 2018-02-25 | Cisplatin 100 + RT(H&N) 1 day | N | null | 10505927 | CISPLATIN + RT |
| 10004038 | 10002547 | 1.68 | 51.4 | Palliative (P) | 2016-08-11 | 2016-08-23 | Irinotecan + Modified De Gramont | 2 | N | 10505945 | IRINOTECAN + MDG |
| 10004039 | 10002548 | 1.6 | 46 | Palliative (P) | 2015-03-30 | 2015-03-30 | Azacitidine | N | N | 10505988 | CHOP |
| 10004040 | 10002549 | 1.52 | 80 | Curative (C) | 2016-06-22 | 2016-07-14 | CISPLATIN + ETOPOSIDE | 02 | Y | 10506002 | CISPLATIN |
| 10004041 | 10002550 | null | 77.9 | Curative (C) | 2016-08-19 | 2016-09-10 | BCG Intravesical | N | N | 10506112 | AZACITIDINE |
| 10004042 | 10002551 | 1.57 | 86 | Disease modification (D) | 2016-07-13 | 2016-07-24 | Abiraterone | 02 | Y | 10506127 | TEMOZOLOMIDE + RT |
| 10004043 | 10002552 | 1.8 | 91.5 | Palliative (P) | 2019-02-14 | 2019-03-01 | FLUOROURACIL + IRINOTECAN | N | N | 10506163 | IRINOTECAN + MDG |
| 10004044 | 10002553 | 1.62 | 62.8 | Palliative (P) | 2018-03-06 | 2018-03-13 | CVD | N | N | 10506179 | CAPECITABINE + CISPLATIN |
| 10004045 | 10002554 | 1.73 | 82 | Adjuvant (A) | 2018-06-08 | 2018-06-18 | Fluorouracil + Folinic Acid Weekly | N | N | 10506212 | FLUOROURACIL |
| 10004046 | 10002555 | 1.7 | 82.6 | Curative (C) | 2016-12-08 | 2016-12-09 | Abiraterone | 02 | null | 10506273 | CISPLATIN |
| 10004047 | 10002556 | 1.77 | 90.7 | Adjuvant (A) | 2018-02-19 | 2018-03-16 | CISPLATIN + RT | N | Y | 10506303 | CISPLATIN + RT |
| 10004048 | 10002557 | 1.83 | null | Curative (C) | 2018-08-05 | 2018-08-25 | Capecitabine 42days + RT | 99 | Y | 10506342 | CAPECITABINE + RT |
| 10004049 | 10002557 | 1.51 | null | Neo-adjuvant (N) | 2017-08-03 | 2017-08-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10506342 | ABIRATERONE |
| 10004050 | 10002557 | 1.62 | 68.7 | Curative (C) | 2014-09-12 | 2014-10-03 | BCG Intravesical | 02 | N | 10506342 | EC |
| 10004051 | 10002558 | null | 68.1 | Disease modification (D) | 2017-10-04 | 2017-10-04 | Abiraterone | null | N | 10506420 | BCG |
| 10004052 | 10002558 | 1.78 | 88.4 | Disease modification (D) | 2016-09-13 | 2016-09-14 | EC | N | N | 10506420 | CHOP |
| 10004053 | 10002558 | 1.7 | null | Adjuvant (A) | 2017-02-19 | 2017-03-09 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10506420 | IMATINIB |
| 10004054 | 10002559 | 0 | 85.9 | Palliative (P) | 2016-07-30 | 2016-09-29 | EC | 02 | Y | 10506602 | TEMOZOLOMIDE + RT |